PT811008E - Derivados biciclicos de benzodiazepina como antagonistas de vasopressina - Google Patents
Derivados biciclicos de benzodiazepina como antagonistas de vasopressinaInfo
- Publication number
- PT811008E PT811008E PT96903711T PT96903711T PT811008E PT 811008 E PT811008 E PT 811008E PT 96903711 T PT96903711 T PT 96903711T PT 96903711 T PT96903711 T PT 96903711T PT 811008 E PT811008 E PT 811008E
- Authority
- PT
- Portugal
- Prior art keywords
- benzodiazepine
- vasopressin antagonists
- bicyclic derivatives
- bicyclic
- derivatives
- Prior art date
Links
- SVUOLADPCWQTTE-UHFFFAOYSA-N 1h-1,2-benzodiazepine Chemical compound N1N=CC=CC2=CC=CC=C12 SVUOLADPCWQTTE-UHFFFAOYSA-N 0.000 title 1
- 229940116211 Vasopressin antagonist Drugs 0.000 title 1
- 229940049706 benzodiazepine Drugs 0.000 title 1
- 239000003038 vasopressin antagonist Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
- A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/373,839 US5696112A (en) | 1995-01-17 | 1995-01-17 | Fused heterocyclic azepines as vasopressin antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT811008E true PT811008E (pt) | 2004-02-27 |
Family
ID=23474102
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT96903711T PT811008E (pt) | 1995-01-17 | 1996-01-16 | Derivados biciclicos de benzodiazepina como antagonistas de vasopressina |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US5696112A (pt) |
| EP (1) | EP0811008B1 (pt) |
| JP (1) | JPH10512572A (pt) |
| KR (1) | KR19980703098A (pt) |
| CN (1) | CN1177356A (pt) |
| AR (1) | AR010195A1 (pt) |
| AT (1) | ATE251166T1 (pt) |
| AU (1) | AU716008B2 (pt) |
| BR (1) | BR9607153A (pt) |
| CA (1) | CA2210571A1 (pt) |
| CZ (1) | CZ224697A3 (pt) |
| DE (1) | DE69630209T2 (pt) |
| DK (1) | DK0811008T3 (pt) |
| EA (1) | EA001427B1 (pt) |
| ES (1) | ES2207672T3 (pt) |
| HU (1) | HUP9800466A3 (pt) |
| IL (1) | IL116776A (pt) |
| MX (1) | MX9705312A (pt) |
| NZ (1) | NZ302119A (pt) |
| PT (1) | PT811008E (pt) |
| TW (1) | TW342385B (pt) |
| WO (1) | WO1996022294A1 (pt) |
| ZA (1) | ZA96298B (pt) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU7338796A (en) * | 1995-11-09 | 1997-05-29 | Japan Tobacco Inc. | Five-membered fused heterocyclic azepine derivatives and pharmaceutical use thereof |
| US6297234B1 (en) | 1999-02-04 | 2001-10-02 | American Home Products Corporation | Arylthiophene vasopressin agonists |
| US6235900B1 (en) | 1999-02-04 | 2001-05-22 | American Home Products Corporation | Tricyclic pyridine N-oxides vasopressin agonists |
| US6437006B1 (en) | 1999-09-27 | 2002-08-20 | American Cyanamid Company | Pharmaceutical carrier formulation |
| BR0208824A (pt) | 2001-04-12 | 2004-03-09 | Wyeth Corp | Composto, métodos de tratamento de distúrbios que são remediados ou aliviados por atividade de agonista de vasopressina em um mamìfero, e de indução de retardamento temporário de urinação em um mamìfero, e, composição farmacêutica |
| US7022699B2 (en) | 2001-04-12 | 2006-04-04 | Wyeth | Cyclohexenyl phenyl diazepines vasopressin and oxytocin receptor modulators |
| US7109193B2 (en) | 2001-04-12 | 2006-09-19 | Wyeth | Tricyclic diazepines tocolytic oxytocin receptor antagonists |
| US6977254B2 (en) * | 2001-04-12 | 2005-12-20 | Wyeth | Hydroxy cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists |
| US6900200B2 (en) | 2001-04-12 | 2005-05-31 | Wyeth | Tricyclic hydroxy carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists |
| CN1516589A (zh) * | 2001-04-12 | 2004-07-28 | 用作加压素激动剂的n-联苯羰基-和n-苯基吡啶基羰基取代的二环和三环氮杂�类和二氮杂�类化合物 | |
| US7064120B2 (en) * | 2001-04-12 | 2006-06-20 | Wyeth | Tricyclic pyridyl carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists |
| US7202239B2 (en) * | 2001-04-12 | 2007-04-10 | Wyeth | Cyclohexylphenyl carboxamides tocolytic oxytocin receptor antagonists |
| US7326700B2 (en) * | 2001-04-12 | 2008-02-05 | Wyeth | Cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists |
| SE0102299D0 (sv) | 2001-06-26 | 2001-06-26 | Astrazeneca Ab | Compounds |
| SE0102764D0 (sv) | 2001-08-17 | 2001-08-17 | Astrazeneca Ab | Compounds |
| EP1632494A1 (en) | 2004-08-24 | 2006-03-08 | Ferring B.V. | Vasopressin v1a antagonists |
| JP4651714B2 (ja) | 2005-07-09 | 2011-03-16 | アストラゼネカ アクチボラグ | 糖尿病の治療においてglk活性化剤として使用するためのヘテロアリールベンズアミド誘導体 |
| BRPI0710479A2 (pt) | 2006-01-18 | 2012-08-14 | Hoffmann La Roche | composto, processo para sua preparaÇço, composiÇço farmacÊutica, uso de um composto e mÉtodo de tratamento de doenÇa ou desosrdem metabàlica. |
| EP2403860B1 (en) * | 2009-03-04 | 2015-11-04 | IDENIX Pharmaceuticals, Inc. | Phosphothiophene and phosphothiazole as hcv polymerase inhibitors |
| WO2010116176A1 (en) | 2009-04-09 | 2010-10-14 | Astrazeneca Ab | Pyrazolo [4, 5-e] pyrimidine derivative and its use to treat diabetes and obesity |
| US10626126B2 (en) | 2016-04-08 | 2020-04-21 | Pulmocide Limited | Compounds |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA821020B (en) * | 1981-02-18 | 1983-10-26 | Thomae Gmbh Dr K | Azepine derivatives, process for their preparation and pharmaceutical compositions thereof |
| US4766108A (en) * | 1986-12-04 | 1988-08-23 | Smith Kline Beckman Corporation | Tyr-Arg-vasopressin antagonists |
| US5055448A (en) * | 1987-06-25 | 1991-10-08 | Medical College Of Ohio | Linear derivatives of arginine vasopressin antagonists |
| DE69009785T2 (de) * | 1989-02-10 | 1994-11-03 | Otsuka Pharma Co Ltd | Carbostyrilderivate. |
| EP0450097B1 (en) * | 1989-10-20 | 1996-04-24 | Otsuka Pharmaceutical Co., Ltd. | Benzoheterocyclic compounds |
| US5258510A (en) * | 1989-10-20 | 1993-11-02 | Otsuka Pharma Co Ltd | Benzoheterocyclic compounds |
| US5070187A (en) * | 1989-11-03 | 1991-12-03 | Trustees Of Boston University | Pharmacologically effective antagonists of arginine-vasopressin |
| TW199153B (pt) * | 1990-08-07 | 1993-02-01 | Dtsuka Seiyaku Kk | |
| CA2066104C (en) * | 1991-04-19 | 2003-05-27 | Hidenori Ogawa | Benzazepine derivatives as vasopressin antagonists |
| EP0533240A3 (en) * | 1991-09-16 | 1993-09-29 | Merck & Co. Inc. | Substituted amine derivatives of piperazinylcamphorsulfonyl oxytocin antagonists |
| DE69223573D1 (de) * | 1991-09-16 | 1998-01-29 | Merck & Co Inc | Hydantoin und Succinimid-substituierte Spiroindanylcamphorsulfonyl als Oxytocin-Antagonisten |
| US5204349A (en) * | 1991-09-16 | 1993-04-20 | Merck & Co., Inc. | Amide-substituted derivatives of spiroindanylcamphorsulfonyl oxytocin antagonists |
| EP0533242A3 (en) * | 1991-09-16 | 1993-09-15 | Merck & Co. Inc. | Substituted derivatives of piperazinylcamphorsulfonyl oxytocin antagonists |
| AU657431B2 (en) * | 1992-08-20 | 1995-03-09 | Otsuka Pharmaceutical Co., Ltd. | Benzoheterocyclic compounds as oxytocin and vasopressin antagonists |
| TW270927B (pt) * | 1992-10-16 | 1996-02-21 | Otsuka Pharma Co Ltd | |
| WO1994012476A1 (fr) * | 1992-11-25 | 1994-06-09 | Yamanouchi Pharmaceutical Co., Ltd. | Derive de benzanilide |
| WO1994014796A1 (fr) * | 1992-12-21 | 1994-07-07 | Yamanouchi Pharmaceutical Co., Ltd. | Nouveau derive de n-(pyridylcarbonyl)benzazepine et son intermediaire |
| WO1994020473A1 (fr) * | 1993-03-11 | 1994-09-15 | Yamanouchi Pharmaceutical Co., Ltd. | Compose avec action antagoniste de la vasopressine |
| GB9307527D0 (en) * | 1993-04-13 | 1993-06-02 | Fujisawa Pharmaceutical Co | New venzamide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same |
-
1995
- 1995-01-17 US US08/373,839 patent/US5696112A/en not_active Expired - Lifetime
- 1995-06-02 US US08/460,418 patent/US5654297A/en not_active Expired - Lifetime
-
1996
- 1996-01-15 ZA ZA96298A patent/ZA96298B/xx unknown
- 1996-01-15 AR ARP960101028A patent/AR010195A1/es not_active Application Discontinuation
- 1996-01-16 HU HU9800466A patent/HUP9800466A3/hu unknown
- 1996-01-16 TW TW085100460A patent/TW342385B/zh active
- 1996-01-16 NZ NZ302119A patent/NZ302119A/en unknown
- 1996-01-16 BR BR9607153A patent/BR9607153A/pt unknown
- 1996-01-16 EA EA199700115A patent/EA001427B1/ru not_active IP Right Cessation
- 1996-01-16 CN CN96192356A patent/CN1177356A/zh active Pending
- 1996-01-16 JP JP8522453A patent/JPH10512572A/ja not_active Ceased
- 1996-01-16 KR KR1019970704946A patent/KR19980703098A/ko not_active Ceased
- 1996-01-16 AU AU47706/96A patent/AU716008B2/en not_active Ceased
- 1996-01-16 ES ES96903711T patent/ES2207672T3/es not_active Expired - Lifetime
- 1996-01-16 DK DK96903711T patent/DK0811008T3/da active
- 1996-01-16 MX MX9705312A patent/MX9705312A/es not_active IP Right Cessation
- 1996-01-16 EP EP96903711A patent/EP0811008B1/en not_active Expired - Lifetime
- 1996-01-16 AT AT96903711T patent/ATE251166T1/de not_active IP Right Cessation
- 1996-01-16 PT PT96903711T patent/PT811008E/pt unknown
- 1996-01-16 IL IL11677696A patent/IL116776A/xx not_active IP Right Cessation
- 1996-01-16 CZ CZ972246A patent/CZ224697A3/cs unknown
- 1996-01-16 DE DE69630209T patent/DE69630209T2/de not_active Expired - Fee Related
- 1996-01-16 WO PCT/US1996/001096 patent/WO1996022294A1/en not_active Ceased
- 1996-01-16 CA CA002210571A patent/CA2210571A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| KR19980703098A (ko) | 1998-10-15 |
| TW342385B (en) | 1998-10-11 |
| BR9607153A (pt) | 1997-11-11 |
| EP0811008A1 (en) | 1997-12-10 |
| WO1996022294A1 (en) | 1996-07-25 |
| US5696112A (en) | 1997-12-09 |
| ZA96298B (en) | 1997-07-15 |
| AU4770696A (en) | 1996-08-07 |
| HUP9800466A2 (hu) | 1998-07-28 |
| CA2210571A1 (en) | 1996-07-25 |
| DK0811008T3 (da) | 2004-01-26 |
| ES2207672T3 (es) | 2004-06-01 |
| NZ302119A (en) | 2000-02-28 |
| AU716008B2 (en) | 2000-02-17 |
| CN1177356A (zh) | 1998-03-25 |
| EA001427B1 (ru) | 2001-02-26 |
| MX9705312A (es) | 1997-10-31 |
| US5654297A (en) | 1997-08-05 |
| IL116776A0 (en) | 1996-05-14 |
| IL116776A (en) | 2000-10-31 |
| EA199700115A1 (ru) | 1997-12-30 |
| HUP9800466A3 (en) | 1998-12-28 |
| EP0811008B1 (en) | 2003-10-01 |
| DE69630209D1 (de) | 2003-11-06 |
| AR010195A1 (es) | 2000-06-07 |
| JPH10512572A (ja) | 1998-12-02 |
| ATE251166T1 (de) | 2003-10-15 |
| DE69630209T2 (de) | 2004-08-19 |
| CZ224697A3 (cs) | 1998-01-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT811008E (pt) | Derivados biciclicos de benzodiazepina como antagonistas de vasopressina | |
| BR9607182A (pt) | Antagonistas de vasopressina de benzazepina tricíclicos | |
| BR9606977A (pt) | Antagonistas de vasopressina de benzazepina triciclica | |
| DK0805813T3 (da) | Tricyclic vasopressin antagonists | |
| BR9607186A (pt) | Antagonistas de vasopressina de benzazepina triciclica | |
| BR9710087A (pt) | Antagonistas de vasopressina de benzazepina tricíclicos | |
| DK0738150T3 (da) | Bicykliske fibrinogene antagonister | |
| BR9612126A (pt) | Derivados de benzazepina | |
| BR9610823A (pt) | Derivados de pirimidina como antagonistas do receptor | |
| BR9707391A (pt) | Pirazolpirimidinas como antagonistas de receptor de crf | |
| EP0868178A4 (en) | GONADOTROPIN RELEASING HORMON ANTAGONISTS | |
| ATE249465T1 (de) | Tricyclische benzodiazepine als vasopressin antagonisten | |
| PT940391E (pt) | Derivados de quinolina como antagonistas do receptor de taquicinina nk3 | |
| EP0986385A4 (en) | GONADORELIN ANTAGONISTS | |
| FI960516L (fi) | Substituoituja bifenyylisulfonamidiendoteliiniantagonisteja | |
| PT1036072E (pt) | Antagonistas de receptores de trombina | |
| PT854867E (pt) | Tetra-hidroquinolinas como antagonistas de nmda | |
| PT746979E (pt) | Utilizacao de compostos pirrolo como agentes anti-incrustadores | |
| FI943808A7 (fi) | Triatsolopyrimidiinijohdannaisia angiotensiini II:n reseptoreiden vast avaikuttajina | |
| EE9700207A (et) | Teraapias kasutatavad bitsüklilised amidiini derivaadid | |
| BR9207071A (pt) | 3-Fenilureído-azepin-2-onas e-benzazepin-2-onas úteis como antagonistas de colecistoquinina | |
| BR1100543A (pt) | antagonistas bicìclicos de fibrinogênio | |
| HK1003264A (en) | Bicyclic benzazepine derivatives as vasopressin antagonists | |
| SI0804438T1 (sl) | Triciklicni benzazepinski antagonisti vazopresina |